Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 1,430,300
Avg Vol 988,150
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 23%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease. The company is also developing HemaXellarate, a cellular therapeutic product of autologous stromal vascular fraction derived from adipose tissue; dCellVax, an autologous dendritic cell which is treated with...

Industry: Biotechnology
Sector: Healthcare
Phone: 619 722 5505
Fax: 619 330 2328
Address:
4700 Spring Street, Suite 304, La Mesa, United States
LoveMonsterCG
LoveMonsterCG Dec. 6 at 3:40 AM
$RGBP Share Structure Update Common Shares 12/05/2025... No changes to the Outstanding Shares for this week's update. No changes to the Restricted and Unrestricted shares. And no changes to shares being Held at DTC. Best wishes everyone! 😊🙏🍀
0 · Reply
LoveMonsterCG
LoveMonsterCG Dec. 6 at 3:40 AM
$RGBP Share Structure Update Preferred Shares 12/5/2025... No changes to the Outstanding Shares. Best wishes everyone! 😊🤙🍀
0 · Reply
TrippinStones
TrippinStones Dec. 6 at 1:30 AM
$RGBP So you don't think Koos benefited from those GISBeX scams? Here's a snapshot of July 2020 when BMSN was trading on just GISBeX. Pumped it from $0.09 all the way to $0.82 and then Hammer dropped it in less than a month. KOOS IS A SERIAL FRAUDSTER
0 · Reply
TrippinStones
TrippinStones Dec. 6 at 1:03 AM
$RGBP This is from a 2005 article tying Koos to the GISBeX prosecution. GISBeX was a private trading firm who P&D'd too many companies to count. Koos had his run with them and skated away. He traded on their platform but says he knows nothing about them 😂 "Bio-Matrix Scientific Group, which says it is a biotech in such areas as adult stem-cell cryogenics, was formerly on GISBeX but isn't now. It changed its name from Storage Suites America last December. It keeps pumping out news releases saying it "is preparing to apply for a stem-cell research grant" or is applying for "a cryogenic stem-cell bank certificate" or applying for "International Society of Stem Cell Research" membership and the like. Self-promotion based on applications is not a good sign. " "We're a developmental-stage company," explains David Koos, chief executive, who says he doesn't know anything about GISBeX" https://share.google/pxQT43g3sswHBRI7T
0 · Reply
TrippinStones
TrippinStones Dec. 6 at 12:49 AM
$RGBP Anyone notice this gem in the supplement? 😁 "WE HAVE NOT OBTAINED PATENT PROTECTION FOR MUCH OF OUR INTELLECTUAL PROPERTY. The Company has not obtained patent protection on much of its intellectual property. Although the Company plans on attempting to obtain patents on its products and services, there can be no assurance that the Company can obtain effective protection against unauthorized duplication or the introduction of substantially similar products."
0 · Reply
LoveMonsterCG
LoveMonsterCG Dec. 5 at 9:45 PM
$RGBP A Supplement to the new Reg A offering Form 1-A was filed today just before the closing bell. It was probably needed to correct something in the prospectus or add something to it that Koos forgot to put in. It doesn't have anything to do with changing the offering price or the amount of shares that can be sold in the offering. That is all still the same. Best wishes everyone! 😊🙏🍀 Link to Supplement filing: https://www.sec.gov/Archives/edgar/data/1589150/000149315225026350/form253g1.htm
0 · Reply
LoveMonsterCG
LoveMonsterCG Dec. 5 at 9:32 PM
$RGBP Closing Chart Common Shares 12/5/2025... $0.0096 +.0006 +6.67% Vol 1,430,359 Pretty good volume day today. But I don't think it had anything to do with shares being distributed from the new Reg A offering. Have a nice weekend everyone! 👍 Best wishes to all! 😊🙏🍀
0 · Reply
LoveMonsterCG
LoveMonsterCG Dec. 5 at 9:32 PM
$RGBP $RGBPP Closing Chart Preferred Shares 12/5/2025... $0.0925 +.0125 +15.63% Vol 350 The preferred shares are totally different than the common shares with hardly any trading activity and volume at all. That's what I don't like about them. They have very little liquidity. Best wishes everyone! 😊🤙🍀
0 · Reply
StockEnthusiast1
StockEnthusiast1 Dec. 5 at 9:22 PM
$RGBP stayed under a penny! Love it. Hopefully none of the volume was the offering being sold when it was slightly over a penny. Lol.
1 · Reply
TrippinStones
TrippinStones Dec. 5 at 8:29 PM
$RGBP Ol TenAss is definitely compensated. But has zero plans of keeping the shares 😂 "Ten Associates LLC intends to sell its shares. If the shares are restricted, TEN ASSOCIATES LLC intends to sell them when they are registered. If the shares are freely tradeable, TEN ASSOCIATES LLC intends to sell them. TEN ASSOCIATES LLC affiliates, officers, directors and employees may buy and sell shares discussed in this report or any other communications and may profit in the event those shares rise in value. TEN ASSOCIATES LLC may sell shares at any time. TEN ASSOCIATES LLC will not advise when it intends to sell and will not offer any opinion as to when others should sell; each Investor must make decisions based on his or her own research and judgment of the market." https://www.tenassociatesllc.com/disclaimer
0 · Reply
Latest News on RGBP
No data available.
LoveMonsterCG
LoveMonsterCG Dec. 6 at 3:40 AM
$RGBP Share Structure Update Common Shares 12/05/2025... No changes to the Outstanding Shares for this week's update. No changes to the Restricted and Unrestricted shares. And no changes to shares being Held at DTC. Best wishes everyone! 😊🙏🍀
0 · Reply
LoveMonsterCG
LoveMonsterCG Dec. 6 at 3:40 AM
$RGBP Share Structure Update Preferred Shares 12/5/2025... No changes to the Outstanding Shares. Best wishes everyone! 😊🤙🍀
0 · Reply
TrippinStones
TrippinStones Dec. 6 at 1:30 AM
$RGBP So you don't think Koos benefited from those GISBeX scams? Here's a snapshot of July 2020 when BMSN was trading on just GISBeX. Pumped it from $0.09 all the way to $0.82 and then Hammer dropped it in less than a month. KOOS IS A SERIAL FRAUDSTER
0 · Reply
TrippinStones
TrippinStones Dec. 6 at 1:03 AM
$RGBP This is from a 2005 article tying Koos to the GISBeX prosecution. GISBeX was a private trading firm who P&D'd too many companies to count. Koos had his run with them and skated away. He traded on their platform but says he knows nothing about them 😂 "Bio-Matrix Scientific Group, which says it is a biotech in such areas as adult stem-cell cryogenics, was formerly on GISBeX but isn't now. It changed its name from Storage Suites America last December. It keeps pumping out news releases saying it "is preparing to apply for a stem-cell research grant" or is applying for "a cryogenic stem-cell bank certificate" or applying for "International Society of Stem Cell Research" membership and the like. Self-promotion based on applications is not a good sign. " "We're a developmental-stage company," explains David Koos, chief executive, who says he doesn't know anything about GISBeX" https://share.google/pxQT43g3sswHBRI7T
0 · Reply
TrippinStones
TrippinStones Dec. 6 at 12:49 AM
$RGBP Anyone notice this gem in the supplement? 😁 "WE HAVE NOT OBTAINED PATENT PROTECTION FOR MUCH OF OUR INTELLECTUAL PROPERTY. The Company has not obtained patent protection on much of its intellectual property. Although the Company plans on attempting to obtain patents on its products and services, there can be no assurance that the Company can obtain effective protection against unauthorized duplication or the introduction of substantially similar products."
0 · Reply
LoveMonsterCG
LoveMonsterCG Dec. 5 at 9:45 PM
$RGBP A Supplement to the new Reg A offering Form 1-A was filed today just before the closing bell. It was probably needed to correct something in the prospectus or add something to it that Koos forgot to put in. It doesn't have anything to do with changing the offering price or the amount of shares that can be sold in the offering. That is all still the same. Best wishes everyone! 😊🙏🍀 Link to Supplement filing: https://www.sec.gov/Archives/edgar/data/1589150/000149315225026350/form253g1.htm
0 · Reply
LoveMonsterCG
LoveMonsterCG Dec. 5 at 9:32 PM
$RGBP Closing Chart Common Shares 12/5/2025... $0.0096 +.0006 +6.67% Vol 1,430,359 Pretty good volume day today. But I don't think it had anything to do with shares being distributed from the new Reg A offering. Have a nice weekend everyone! 👍 Best wishes to all! 😊🙏🍀
0 · Reply
LoveMonsterCG
LoveMonsterCG Dec. 5 at 9:32 PM
$RGBP $RGBPP Closing Chart Preferred Shares 12/5/2025... $0.0925 +.0125 +15.63% Vol 350 The preferred shares are totally different than the common shares with hardly any trading activity and volume at all. That's what I don't like about them. They have very little liquidity. Best wishes everyone! 😊🤙🍀
0 · Reply
StockEnthusiast1
StockEnthusiast1 Dec. 5 at 9:22 PM
$RGBP stayed under a penny! Love it. Hopefully none of the volume was the offering being sold when it was slightly over a penny. Lol.
1 · Reply
TrippinStones
TrippinStones Dec. 5 at 8:29 PM
$RGBP Ol TenAss is definitely compensated. But has zero plans of keeping the shares 😂 "Ten Associates LLC intends to sell its shares. If the shares are restricted, TEN ASSOCIATES LLC intends to sell them when they are registered. If the shares are freely tradeable, TEN ASSOCIATES LLC intends to sell them. TEN ASSOCIATES LLC affiliates, officers, directors and employees may buy and sell shares discussed in this report or any other communications and may profit in the event those shares rise in value. TEN ASSOCIATES LLC may sell shares at any time. TEN ASSOCIATES LLC will not advise when it intends to sell and will not offer any opinion as to when others should sell; each Investor must make decisions based on his or her own research and judgment of the market." https://www.tenassociatesllc.com/disclaimer
0 · Reply
Tejay73
Tejay73 Dec. 5 at 6:34 PM
$RGBP how is it that every time they pay for one of those goldman reports, tenassociates also starts posting "news soon". Koos so obviously pays this dude. Where's the "news soon" from last time jerk.
3 · Reply
tenassociates33
tenassociates33 Dec. 5 at 5:45 PM
$RGBP $0.02 soon
1 · Reply
StockEnthusiast1
StockEnthusiast1 Dec. 5 at 4:05 PM
$RGBP 800k shares traded so far. People just don't learn. Same report over and over again.....lessons will be taught. At this point I hope it stays under .01 just so he cant sell any on the new offering. Then take the f#cking massive amount of money hes already diluted for and start the damn trials! He already has the money.....whats the hold up?! Oh yeah, he's crooked and never intended to use the money for trials and instead will be keeping for himself. Thats more plausible at this point.
2 · Reply
TrippinStones
TrippinStones Dec. 5 at 3:26 PM
$RGBP Big news huh? @tenassociates33 😂 So he's going to announce that some sketchy fund is buying shares and that he's going to raise the money to put a drug that no one wanted for 10 years into clinical trials with a cro who has only, and I mean EVER, completed a clinical trial using sandalwood oil. 🙄 Oh and before I forget, he has 'applied' (super vague) For a 950,000$ Grant. And he 'expects' to hear something back soon. Maybe you could get him to announce why he's carrying two toxic notes from 2016 and 17 that are related party and won't close those out. Or why he never provides any data on anything whatsoever. Or why he's even accruing a salary when he's not doing jack sh*t. Just a few suggestions. Especially since you're such an insider... 😂😂😂😂
1 · Reply
LoveMonsterCG
LoveMonsterCG Dec. 5 at 3:07 PM
$RGBP Good morning! Holy moly! 592,000 shares traded in the first 30 minutes this morning. All trades have been in the green mostly at .01. Could be an interesting day. Best wishes everyone! 😊🙏🍀
1 · Reply
tenassociates33
tenassociates33 Dec. 5 at 2:49 PM
$RGBP Big new coming early next week. Cheap prices..
1 · Reply
Paulshappy
Paulshappy Dec. 5 at 3:26 AM
$RGBP Instead of these paid for reports about all the possibilities, drop phase 1 news. He's definitely trying to get this over a penny to sell his new offering shares.
1 · Reply
LoveMonsterCG
LoveMonsterCG Dec. 5 at 1:57 AM
$RGBP Here is the updated research report which just came out today. While it is intriguing that in comparison to other small biotech companies similar to Regen BioPharma, the market value of the company is definitely very underpriced. We just need a catalyst that would drive the share price up to a more respectable level, but one that would be based upon some real results like the start of a Phase I trial. We really need that to happen for us to get anywhere here IMO. 😊👍 Best wishes everyone! 😊🙏🍀 https://goldmansmallcapresearch.com/opportunity-research/shares-poised-to-enjoy-strong-start-to-2026/
0 · Reply
StockEnthusiast1
StockEnthusiast1 Dec. 4 at 11:03 PM
$RGBP yet another Goldman sacks report out on "X". Funny how Koos needs to get this over a penny all of a sudden theres a "report" that comes out. Atrocious and manipulation at its finest.
1 · Reply
LoveMonsterCG
LoveMonsterCG Dec. 4 at 9:33 PM
$RGBP Closing Chart Common Shares 12/4/2025... $0.009 Unchanged Vol 230,333 Best wishes everyone! 😊🙏🍀
0 · Reply
LoveMonsterCG
LoveMonsterCG Dec. 4 at 9:33 PM
$RGBP $RGBPP Closing Chart Preferred Shares 12/4/2025... $0.08 -.001 -1.24% Vol 48,072 Best wishes everyone! 😊🤙🍀
0 · Reply
Geepers
Geepers Dec. 4 at 7:00 PM
$RGBP What’s the BS they are going to spew about at the next conference. I wonder how many people type jacked up questions or flat call koosy names on the emerging growth conference and that lady is just trying to keep a straight face whilst reading questions…
0 · Reply